186 related articles for article (PubMed ID: 19446653)
21. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies.
Gupta AK; Wells S
IEEE Trans Nanobioscience; 2004 Mar; 3(1):66-73. PubMed ID: 15382647
[TBL] [Abstract][Full Text] [Related]
22. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
23. Chitosan-based luminescent/magnetic hybrid nanogels for insulin delivery, cell imaging, and antidiabetic research of dietary supplements.
Shen JM; Xu L; Lu Y; Cao HM; Xu ZG; Chen T; Zhang HX
Int J Pharm; 2012 May; 427(2):400-9. PubMed ID: 22342466
[TBL] [Abstract][Full Text] [Related]
24. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.
Schleich N; Po C; Jacobs D; Ucakar B; Gallez B; Danhier F; Préat V
J Control Release; 2014 Nov; 194():82-91. PubMed ID: 25178270
[TBL] [Abstract][Full Text] [Related]
25. Bis-phosphonates-ultra small superparamagnetic iron oxide nanoparticles: a platform towards diagnosis and therapy.
Lalatonne Y; Paris C; Serfaty JM; Weinmann P; Lecouvey M; Motte L
Chem Commun (Camb); 2008 Jun; (22):2553-5. PubMed ID: 18506241
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional magnetic nanoparticles for targeted imaging and therapy.
McCarthy JR; Weissleder R
Adv Drug Deliv Rev; 2008 Aug; 60(11):1241-1251. PubMed ID: 18508157
[TBL] [Abstract][Full Text] [Related]
27. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.
Kievit FM; Veiseh O; Fang C; Bhattarai N; Lee D; Ellenbogen RG; Zhang M
ACS Nano; 2010 Aug; 4(8):4587-94. PubMed ID: 20731441
[TBL] [Abstract][Full Text] [Related]
28. Development of magnetic chromatography to sort polydisperse nanoparticles in ferrofluids.
Forge D; Gossuin Y; Roch A; Laurent S; Elst LV; Muller RN
Contrast Media Mol Imaging; 2010; 5(3):126-32. PubMed ID: 20586034
[TBL] [Abstract][Full Text] [Related]
29. Multimodal superparamagnetic nanoplatform for clinical applications: immunoassays, imaging & therapy.
Motte L; Benyettou F; de Beaucorps C; Lecouvey M; Milesovic I; Lalatonne Y
Faraday Discuss; 2011; 149():211-25; discussion 227-45. PubMed ID: 21413183
[TBL] [Abstract][Full Text] [Related]
30. Model-based optimized steering and focusing of local magnetic particle concentrations for targeted drug delivery.
Van Durme R; Crevecoeur G; Dupré L; Coene A
Drug Deliv; 2021 Dec; 28(1):63-76. PubMed ID: 33342319
[TBL] [Abstract][Full Text] [Related]
31. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration.
Chertok B; David AE; Yang VC
Biomaterials; 2010 Aug; 31(24):6317-24. PubMed ID: 20494439
[TBL] [Abstract][Full Text] [Related]
32. Glycolic acid functionalized chitosan-Au-Fe₃O₄ hybrid nanoparticle based nanohybrid scaffold for drug delivery.
Kumari S; Singh RP
Int J Biol Macromol; 2013 Mar; 54():244-9. PubMed ID: 23237797
[TBL] [Abstract][Full Text] [Related]
33. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
[TBL] [Abstract][Full Text] [Related]
34. Use of PEI-coated magnetic iron oxide nanoparticles as gene vectors.
Wei W; Xu C; Wu H
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(6):618-20. PubMed ID: 15791859
[TBL] [Abstract][Full Text] [Related]
35. Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads.
Gu L; Park JH; Duong KH; Ruoslahti E; Sailor MJ
Small; 2010 Nov; 6(22):2546-52. PubMed ID: 20814923
[TBL] [Abstract][Full Text] [Related]
36. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
[TBL] [Abstract][Full Text] [Related]
37. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
38. Magnetic PECA nanoparticles as drug carriers for targeted delivery: synthesis and release characteristics.
Yang J; Lee H; Hyung W; Park SB; Haam S
J Microencapsul; 2006 Mar; 23(2):203-12. PubMed ID: 16754376
[TBL] [Abstract][Full Text] [Related]
39. Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?
Bietenbeck M; Florian A; Faber C; Sechtem U; Yilmaz A
Int J Nanomedicine; 2016; 11():3191-203. PubMed ID: 27486321
[TBL] [Abstract][Full Text] [Related]
40. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
